Document

Restructure Medicare & Medicaid: In Addition to Life Expectancy, USA Falls

Ref IMAGES-006-HOUSE_OVERSIGHT_021000.txt Release House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pages

Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.

View the original on the official release

Document text

Text is machine OCR and may contain errors. Confirm against the original source above.

Restructure Medicare & Medicaid: In Addition to Life Expectancy, USA Falls Behind OECD Averages in Many Other Health Indicators OECD USA Ranking 2007 Health Indicators USA Median (1 = Best, 30 = Worst) RED = Below Average Obesity (% of total population) 34 15 30 Infant Mortality (per 1,000 live births) 7 4 27 Medical Resources Available (per 1,000 population) Total Hospital Beds 3 6 25 Practicing Physicians 2 3 22 Doctors’ Consultations per Year 4, 6 19 MRI Machines* (per million population) 26 9 1 Cause of Death (per 100,000 population) Heart Attack 216 178 22 Respiratory Diseases 60 45 21 Diabetes 20 12 20 Cancer 158 159 14 Stroke 33 45 8 KP Note: *MRI is Magnetic Resonance Imaging. Source: OECD. i USA Inc. | What Might a Turnaround Expert Consider? 317 Restructure Medicare & Medicaid: Effectiveness Research Could Improve Efficiency (i.e., Outputs Track Inputs) e Comparative Effectiveness evaluates different options for treating a condition for a specific set of patients’ — Either relative benefits and risks of various treatment options (technology assessment, evidence-based medicine), or — Both clinical effectiveness and relative cost (cost-benefit analysis). e Without rigorous data about comparative effectiveness, according to the CBO: — Treatment decisions often depend on anecdotal evidence, conjecture, and the experience/judgment of involved physicians. — Treatments and types of care vary widely from one area of the country to another. e To affect healthcare spending meaningfully, comparative effectiveness must alter doctor and patient behavior, potentially through reimbursement scheme changes, the CBO notes. e Note that by law, Medicare is effectively precluded from considering costs when making coverage decisions. K P Source: “Research on the Comparative Effectiveness of Medical Treatments”, A CBO Paper, December 2007. www.kpcb.com ne. at Might a Turnaround Expert Consider? B kpeb USA Inc. | What Might a T dE Consider? 318 HOUSE_OVERSIGHT_021000

Have a question about what this document contains?

Ask the documents